Loading company…
NCPC Genetech researches, manufactures and sells recombinant protein drugs and vaccines.
Founded in 1997 in Shijiazhuang, China, NCPC Genetech is a joint venture between North China Pharmaceutical Group and British Moye Biotechnology Development. It researches, develops, manufactures and sells recombinant protein drugs and vaccines, including erythropoietin and colony-stimulating factor injections. In June 2024, Bank of Communications Investment agreed to invest CNY 900 million in the company.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in